LivCor Australia is a health care startup based in Australia that focuses on providing solutions to save lives. Founded in 1988, the company is now taking orders for the CellAED®, which is touted as the world's most affordable and easy-to-use personal defibrillator. Additionally, LivCor delivers nationally accredited first aid, CPR, safety, and wellbeing courses to a range of clients across the country. The company also equips registered training organizations (RTOs) and first aid training industry professionals with the necessary manikins, equipment, learning resources, and tools to deliver highly engaging and compliant training. LivCor's training partnerships allow third parties to run their own training under the company's RTO registration. LivCor Australia's commitment to providing accessible and essential life-saving equipment, coupled with their comprehensive approach to training and education in first aid and CPR, positions them at the forefront of the health care industry. The emphasis on affordability and ease of use with their flagship product, the CellAED®, aligns with the growing demand for accessible and user-friendly health care solutions. With a clear focus on saving lives and preventing health emergencies, LivCor Australia presents an impactful opportunity for venture capital investment to support their mission of making life-saving equipment and training more widely available. The potential for expansion and innovation within the health care sector makes LivCor Australia an attractive prospect for venture capital firms looking to invest in impactful and socially beneficial ventures.
There is no investment information
No recent news or press coverage available for LivCor Australia.